Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled time : 12:03 save search
U.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS Disorders
Published: 2021-03-08 (Crawled : 12:03) - globenewswire.com
PASG | $1.26 2.44% 24K
|
Health Technology
|
| O: 5.85%
H: 1.71%
C: -7.29%
food gene therapy therapy drug fast track gene therapies fast track designation grant designation rare
Kura Oncology Receives FDA Breakthrough Therapy Designation for Tipifarnib in Head and Neck Squamous Cell Carcinoma
Published: 2021-02-24 (Crawled : 12:03) - globenewswire.com
KURA | $18.55 -2.42% 270K
|
Health Technology
|
| O: 2.4%
H: 1.79%
C: -14.57%
fda therapy clinical oncology virtual scientific program breakthrough therapy designation cell carcinoma
Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.3%
H: 3.92%
C: -0.6%
gene therapies svb leerink global therapy gene therapy
Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020
Published: 2021-02-09 (Crawled : 12:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 1.68%
H: 19.21%
C: 13.91%
results financial results gene therapies therapy gene therapy
CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT
Published: 2021-02-05 (Crawled : 12:03) - globenewswire.com
CDNA 4 | $7.975 -2.74% 200K
|
Health Technology
|
| O: -0.48%
H: 3.51%
C: -0.49%
therapy
Sio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle Therapeutics
Published: 2021-02-04 (Crawled : 12:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 5.63%
H: 1.49%
C: -3.67%
gene therapies therapy gene therapy
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
Published: 2021-02-03 (Crawled : 12:03) - globenewswire.com
CMPS | $8.75 5.17% 340K
|
Health Technology
|
| O: 1.15%
H: 9.78%
C: 5.53%
therapy train psilocybin
Trevena, Inc. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy
Published: 2021-01-28 (Crawled : 12:03) - globenewswire.com
TRVN | $0.3801 -0.34% 28K
|
Health Technology
|
| O: 0.91%
H: 5.86%
C: -1.35%
therapy respiratory risk
Oncorus Announces Publication of Preclinical Data Demonstrating Potent Systemic Antitumor Activity of its Clinical Stage Oncolytic Herpes Simplex Viral Immunotherapy Product Candidate ONCR-177
Published: 2021-01-20 (Crawled : 12:03) - globenewswire.com
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: 2.71%
H: 0.94%
C: -7.51%
therapy immunotherapy preclinical pre-clinical
Orchard Therapeutics Announces OTL-200 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by FDA for the Treatment of Metachromatic Leukodystrophy (MLD)
Published: 2021-01-14 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -1.61%
H: 15.66%
C: 14.36%
therapy fda treatment designation rmat
Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.12%
H: 8.69%
C: -7.31%
gene therapy therapy stem cell expansion commercialization gene therapies application
Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
Published: 2021-01-04 (Crawled : 12:03) - globenewswire.com
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: 0.62%
H: 4.4%
C: 1.75%
immunotherapy therapy
Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis
Published: 2021-01-04 (Crawled : 12:03) - globenewswire.com
PASG | $1.26 2.44% 24K
|
Health Technology
|
| O: 2.35%
H: 11.2%
C: 7.45%
gene therapy fda clearance fda therapy treatment gene therapies application clearance
PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program
Published: 2020-12-22 (Crawled : 12:03) - globenewswire.com
PYPD | $4.5 400
|
Health Technology
|
| O: -0.75%
H: 15.46%
C: 0.75%
cancer positive therapy preclinical pre-clinical
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.